Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer-Reference-Cited by-同舟云学术

Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer

Published:2023-10-13 Issue:12 Volume:101 Page:1603-1614
ISSN:0946-2716
Container-title:Journal of Molecular Medicine
language:en
Short-container-title:J Mol Med

Author:

Takatsu Fumiaki,Suzawa Ken^ORCID,Tomida Shuta,Thu Yin Min,Sakaguchi Masakiyo,Toji Tomohiro,Ohki Masayoshi,Tsudaka Shimpei,Date Keiichi,Matsuda Naoki,Iwata Kazuma,Zhu Yidan,Nakata Kentaro,Shien Kazuhiko,Yamamoto Hiromasa,Nakayama Akiko,Okazaki Mikio,Sugimoto Seiichiro,Toyooka Shinichi

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Drug Discovery,Molecular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00109-023-02384-7.pdf

Reference36 articles.

1. Alexander M, Kim SY, Cheng H (2020) Update 2020: Management of Non-Small Cell Lung Cancer. Lung 198:897–907. https://doi.org/10.1007/s00408-020-00407-5

2. Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423–1437. https://doi.org/10.1038/nm.3394

3. Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R (2019) Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol Cancer 18:70. https://doi.org/10.1186/s12943-019-0994-2